In vivo imaging of molecular targets and their function in endocrinology
- 31 March 2008
- journal article
- review article
- Published by Bioscientifica in Journal of Molecular Endocrinology
- Vol. 40 (6) , 253-261
Abstract
Imaging is one of the fastest growing fields of study. New technologies and multimodal approaches are increasing the application of imaging to determine molecular targets and functional processes in vivo. The identification of a specific target, transporter, or biological process using imaging has introduced major breakthroughs to the field of endocrinology primarily utilizing computed tomography, magnetic resonance imaging, ultrasonography, positron emission tomography, single-photon emission computed tomography, and optical imaging. This review provides a general background to the specific developments in imaging that pertains to in vivo function and target identification in endocrine-based diseases.Keywords
This publication has 68 references indexed in Scilit:
- A secreted luciferase for ex vivo monitoring of in vivo processesNature Methods, 2008
- Functional Imaging of Estrogen Receptors with Radiolabeled-GAP-EDL in Rabbit Endometriosis ModelAcademic Radiology, 2007
- Multimodal MRI contrast agentsJBIC Journal of Biological Inorganic Chemistry, 2007
- The nonpeptidyl caspase binding radioligand (S)-1-(4-(2-[18F]Fluoroethoxy)-benzyl)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin ([18F]CbR) as potential positron emission tomography-compatible apoptosis imaging agent.2007
- Multimodal imaging of mouse development: Tools for the postgenomic eraDevelopmental Dynamics, 2006
- Neuroendocrine tumors and somatostatin: imaging techniques.2005
- In Vivo Imaging of Activated Estrogen Receptors in Utero by Estrogens and Bisphenol AEnvironmental Health Perspectives, 2004
- A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation.2003
- Isotopic evaluation and therapy in patients with malignant endocrine diseaseBest Practice & Research Clinical Endocrinology & Metabolism, 2001
- PET imaging of breast cancer with fluorine-18 radiolabeled estrogens and progestins.1998